LABCORP HOLDINGS INC (LH) Stock Price, Forecast & Analysis
USA - NYSE:LH - US5049221055 - Common Stock
LH Key Statistics, Chart & Performance
The current stock price of LH is 266.91 USD. In the past month the price decreased by -4.14%. In the past year, price increased by 14.03%.
LH Latest News, Press Relases and Analysis
LH Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.86 | 103.05B | ||
| CI | THE CIGNA GROUP | 9.63 | 73.01B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.3 | 21.06B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 112.65 | 20.35B | ||
| GH | GUARDANT HEALTH INC | N/A | 12.01B | ||
| HIMS | HIMS & HERS HEALTH INC | 72.62 | 8.86B | ||
| DVA | DAVITA INC | 13.55 | 8.94B | ||
| CHE | CHEMED CORP | 20.62 | 6.61B | ||
| RDNT | RADNET INC | 202.79 | 5.93B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 33.57 | 6.07B | ||
| OPCH | OPTION CARE HEALTH INC | 19.26 | 4.66B | ||
| WGS | GENEDX HOLDINGS CORP | 72.36 | 3.91B |
Related stock screener links
About LH
Company Profile
Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 70,000 full-time employees. The firm provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Company Info
LABCORP HOLDINGS INC
358 S Main St
Burlington NORTH CAROLINA 27215 US
CEO: Adam H. Schechter
Employees: 70000
Phone: 13362291127
LABCORP HOLDINGS INC / LH FAQ
Can you describe the business of LABCORP HOLDINGS INC?
Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 70,000 full-time employees. The firm provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
What is the stock price of LABCORP HOLDINGS INC today?
The current stock price of LH is 266.91 USD. The price decreased by -0.48% in the last trading session.
Does LH stock pay dividends?
LABCORP HOLDINGS INC (LH) has a dividend yield of 1.17%. The yearly dividend amount is currently 2.91.
How is the ChartMill rating for LABCORP HOLDINGS INC?
LH has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What do analysts say about LABCORP HOLDINGS INC (LH) stock?
29 analysts have analysed LH and the average price target is 307.03 USD. This implies a price increase of 15.03% is expected in the next year compared to the current price of 266.91.
What is the GICS sector and industry of LH stock?
LABCORP HOLDINGS INC (LH) operates in the Health Care sector and the Health Care Providers & Services industry.
What is the expected growth for LH stock?
The Revenue of LABCORP HOLDINGS INC (LH) is expected to grow by 7.86% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
LH Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to LH. When comparing the yearly performance of all stocks, LH turns out to be only a medium performer in the overall market: it outperformed 61.28% of all stocks.
LH Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to LH. Both the profitability and the financial health of LH get a neutral evaluation. Nothing too spectacular is happening here.
LH Financial Highlights
Over the last trailing twelve months LH reported a non-GAAP Earnings per Share(EPS) of 15.82. The EPS increased by 9.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.21% | ||
| ROA | 4.68% | ||
| ROE | 9.83% | ||
| Debt/Equity | 0.59 |
LH Forecast & Estimates
29 analysts have analysed LH and the average price target is 307.03 USD. This implies a price increase of 15.03% is expected in the next year compared to the current price of 266.91.
For the next year, analysts expect an EPS growth of 15.41% and a revenue growth 7.86% for LH